ABOUT THIS EPISODE
In this episode of Med Tech Talks, Robert Klupacs is joined by Dr Alastair Hick, Chief Commercialisation Officer at Monash University.
With a PhD in Chemical Ecology and an MBA from the Judge Business School at the University of Cambridge, Alastair has a wealth of experience both in Australian and overseas markets and brings an ecosystem approach to commercialisation and innovation.
At Monash University, Alastair has been responsible has developed a successful IP commercialisation program and an also oversees The Generator, a hub that develops the entrepreneurial talent of Monash’s students, staff, and alumni.
Alastair has recently established a $15 million Monash/Breakthrough Victoria Pre-Seed fund and is chair of its investment committee. He was also a founding director of the $30 million Trans-Tasman Commercialisation Fund; is a director of Monash University spinouts Jupiter Ionics, Phrenix Therapeutics, Myostellar and Flex Immunotherapeutics; as well as an early-stage investor Uniseed and therapeutics development company BioCurate.
In this episode, you will learn from Alastair about:
- The evolution of the commercialisation ecosystem at Monash University
- The role of entrepreneurial talent in innovation success
- Challenges in scaling and accessing investment
- Potential role of the government in supporting Australian innovation
- The importance of mentorship and confidence in entrepreneurship.
Learn more about Dr Alastair Hick.
Learn more about The Generator.
Updated version 05/08/22
